Table 3.
Relapse | Failure | Treatment after loss to follow-up | P value | |
---|---|---|---|---|
Total | 147 | 78 | 16 | |
Sex | ||||
Male | 102 (69.4) | 56 (71.8) | 16 (100) | 0.03 |
Female | 45 (30.6) | 22 (28.2) | — | 0.03 |
Age (years) | ||||
00–24 | 10 (6.8) | 10 (12.8) | 1 (6.3) | 0.29 |
25–44 | 86 (58.5) | 42 (53.8) | 8 (50) | 0.69 |
45–64 | 42 (28.6) | 22 (28.2) | 6 (37.5) | 0.74 |
65 and + | 9 (6.1) | 4 (5.1) | 1 (6.3) | — |
Regions | ||||
Atacora-Donga | 8 (5.4) | 6 (7.7) | 0 | — |
Borgou-Alibori | 7 (4.8) | 6 (7.7) | 0 | — |
Zou-Collines | 16 (10.9) | 16 (20.5) | 1 (6.3) | 0.09 |
Mono-Couffo | 16 (10.9) | 12 (15.4) | 1 (6.3) | 0.46 |
Oueme-Plateau | 27 (18.4) | 10 (12.8) | 10 (62.5) | 0.00002 |
Atlantique-Littoral | 73 (49.7) | 28 (35.9) | 4 (25) | 0.04 |
HIV status | ||||
HIV positive | 27 (18.4) | 14 (17.9) | 2 (12.5) | 0.84 |
HIV negative | 116 (78.9) | 63 (80.8) | 14 (87.5) | 0.70 |
Unknown | 4 (2.7) | 1 (1.3) | 0 | — |